Belmond Ltd. Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheet

In millions of USD, except per-share amounts

	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jun 30, 2016	Q1 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q3 FY2015 As of Sep 30, 2015	Q2 FY2015 As of Jun 30, 2015	Q1 FY2015 As of Mar 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q3 FY2014 As of Sep 30, 2014	Q2 FY2014 As of Jun 30, 2014	Q1 FY2014 As of Mar 31, 2014
Assets
Cash and cash equivalents
Restricted cash
Accounts receivable, net of allowances of $539 and $544
Due from unconsolidated companies
Prepaid expenses and other
Inventories
Assets held for sale
Total current assets
Property, plant and equipment, net of accumulated depreciation of $439,767 and $417,738
Property, plant and equipment of consolidated variable interest entities
Investments in unconsolidated companies
Goodwill
Other intangible assets
Pension assets
Other assets
Total assets

Liabilities and Equity
Working capital loans
Accounts payable
Accrued liabilities
Liabilities held for sale
Deferred revenue
Current portion of long-term debt and obligations under capital leases
Current portion of long-term debt of consolidated variable interest entities
Total current liabilities
Long-term debt and obligations under capital leases
Long-term debt of consolidated variable interest entities
Liability for pension benefit
Other liabilities
Deferred income taxes of consolidated variable interest entities
Deferred income taxes
Liability for uncertain tax positions
Total liabilities
Equity:
Shareholders’ equity:
Preferred shares $0.01 par value (30,000,000 shares authorized, issued Nil)
Common stock, value
Class A common shares at par value
Class B common shares at par value
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Less: Reduction due to class B common shares owned by a subsidiary — 18,044,478 (2013 — 18,044,478)
Less: Reduction due to class B common shares owned by a subsidiary — 18,044,478 (2017 - 18,044,478)
Total shareholders’ equity

Non-controlling interests
Total equity

Total liabilities and equity

Comments